advertisement

Topcon

Frontiers in immunology 15

Showing records 1 to 15 | Display all abstracts in Frontiers in immunology

107691 Enhanced glaucomatous damage accompanied by glial response in a new multifactorial mouse model
Reinehr S
Frontiers in immunology 2022; 13: 1017076
107708 Protective effects of blocking PD-1 pathway on retinal ganglion cells in a mouse model of chronic ocular hypertension
Sheng S
Frontiers in immunology 2022; 13: 1094132
108319 Ankylosing spondylitis and glaucoma in European population: A Mendelian randomization study
Li S; Chen M
Frontiers in immunology 2023; 14: 1120742
107708 Protective effects of blocking PD-1 pathway on retinal ganglion cells in a mouse model of chronic ocular hypertension
Ma Y
Frontiers in immunology 2022; 13: 1094132
107691 Enhanced glaucomatous damage accompanied by glial response in a new multifactorial mouse model
Girbig RM
Frontiers in immunology 2022; 13: 1017076
108319 Ankylosing spondylitis and glaucoma in European population: A Mendelian randomization study
Zhang Q
Frontiers in immunology 2023; 14: 1120742
107691 Enhanced glaucomatous damage accompanied by glial response in a new multifactorial mouse model
Schulte KK
Frontiers in immunology 2022; 13: 1017076
107708 Protective effects of blocking PD-1 pathway on retinal ganglion cells in a mouse model of chronic ocular hypertension
Zou Y
Frontiers in immunology 2022; 13: 1094132
108319 Ankylosing spondylitis and glaucoma in European population: A Mendelian randomization study
Fang M
Frontiers in immunology 2023; 14: 1120742
107691 Enhanced glaucomatous damage accompanied by glial response in a new multifactorial mouse model
Theile J
Frontiers in immunology 2022; 13: 1017076
107708 Protective effects of blocking PD-1 pathway on retinal ganglion cells in a mouse model of chronic ocular hypertension
Hu F; Chen L
Frontiers in immunology 2022; 13: 1094132
108319 Ankylosing spondylitis and glaucoma in European population: A Mendelian randomization study
Xiong W
Frontiers in immunology 2023; 14: 1120742
107691 Enhanced glaucomatous damage accompanied by glial response in a new multifactorial mouse model
Asaad MA; Fuchshofer R
Frontiers in immunology 2022; 13: 1017076
108319 Ankylosing spondylitis and glaucoma in European population: A Mendelian randomization study
Bai L
Frontiers in immunology 2023; 14: 1120742
107691 Enhanced glaucomatous damage accompanied by glial response in a new multifactorial mouse model
Dick HB; Joachim SC
Frontiers in immunology 2022; 13: 1017076

Issue 23-4

Change Issue


advertisement

WGA Rescources